Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Immunobiology ; 226(5): 152133, 2021 09.
Article in English | MEDLINE | ID: mdl-34469785

ABSTRACT

BACKGROUND AND AIMS: Pyroptosis is a relatively newly discovered form of programmed cell death that plays an important role in the development of atherosclerosis. Many studies have reported that lncRNAs participated in the regulation of atherosclerosis development. However, the regulatory mechanism of lncRNAs in pyroptosis must be studied further. METHODS: In a previous study, microarray analysis was used to detect the lncRNA expression profile in three human advanced atherosclerotic plaques and three normal arterial intimae. In the present research, in vitro assays were performed to investigate the role of lncRNA RP11-490M8.1 on pyroptosis. The relative gene mRNA and lncRNA expression levels were tested by quantitative real-time PCR, and protein levels were evaluated by western blot analysis. The RNA hybrid structure was analyzed using the DINAMelt server. RESULTS: The lncRNA RP11-490M8.1 was significantly downregulated in atherosclerotic plaques and serum. Lipopolysaccharide (LPS) markedly reduced the expression of lncRNA RP11-490M8.1 and induced pyroptosis by increasingthe mRNA and protein levels of NLRP3, caspase-1, ASC, IL-1ß, and IL-18 in HUVECs. The promotion effects ofLPS on pyroptosis were markedly suppressed by overexpression of lncRNA RP11-490M8.1. In addition, LPS increased the mRNA and protein levels ofTLR4 and NF-κB, which was also markedly offsetby overexpression of lncRNA RP11-490M8.1. CONCLUSIONS: These findings indicated that lncRNA RP11-490M8.1 inhibited LPS-induced pyroptosis via the TLR4/NF-κB pathway. Thus, lncRNA RP11-490M8.1 may provide a therapeutic target to ameliorate atherosclerosis.


Subject(s)
Human Umbilical Vein Endothelial Cells , NF-kappa B , Pyroptosis , RNA, Long Noncoding , Toll-Like Receptor 4 , Atherosclerosis/genetics , CARD Signaling Adaptor Proteins/genetics , Caspase 1/genetics , Cells, Cultured , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Inflammasomes/genetics , Inflammasomes/metabolism , Interleukin-18/genetics , Interleukin-1beta/genetics , Lipopolysaccharides/pharmacology , NF-kappa B/genetics , NF-kappa B/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Pyroptosis/drug effects , RNA, Messenger , Signal Transduction/drug effects , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism
2.
Sci Total Environ ; 752: 141887, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-32890836

ABSTRACT

Coke powders in the coking wastewater generated by petroleum refining industry needs to be removed to achieve water reuse for lack of water resources. This study developed a decoking hydrocyclone in the closed coking wastewater circulation treatment system to remove coke powders, which was highly efficient and environmentally friendly. Computational Fluid Dynamics (CFD) method was carried out to study the tangential velocity distribution index n-value to guide design of decoking hydrocyclone and experiment was conducted to verify the coke powders removal effect. It was found that the increase of n-value is conducive to the improvement of coke powders separation efficiency. A decoking hydrocyclone with a cone angle of 15° and an inlet size of 4 × 6 mm is the optimum hydrocyclone and the recovery efficiency of coke powders is stable at more than 90%. It is the first time for hydrocyclone successfully applied to the removal of coke powders in coking wastewater in the decoking process of petroleum refining industry, in which the separation efficiency of coke powders is considerably improved.

3.
Arch Insect Biochem Physiol ; 105(1): e21720, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32557681

ABSTRACT

The large-conductance calcium-activated potassium channel (BKCa ) plays an important role in the regulation of insect neural circuits and locomotion, and thus is a potential target of insecticides. In this study, iberiotoxin, an inhibitor of BKCa , was found to prolong the anesthetic time of ethyl acetate on Plutella xylostella larvae. Therefore, the coding sequence of slowpoke gene coding the alpha subunit of BKCa was cloned to investigate the function of this channel in P. xylostella, and the gene expression profile in the developmental stages and tissues was also characterized. The total length of pxslo DNA was more than 19.9 kb, which harbored four alternative splicing sites (ASP-A, ASP-C, ASP-E, and ASP-G), and the coding sequence of pxslo with the highest frequency of splicing (GenBank ID: MN938456) was 3,405 base pair. The characterized PxSlo protein contained conserved domains previously identified in other insects. Quantitative reverse transcription-polymerase chain reaction analysis showed that pxslo was expressed in all the developmental stages of P. xylostella, with the highest level in adults. In the larval stage, pxslo was mainly expressed in the head and epidermis, while a limited protein was expressed in the midgut. In the adult stage, pxslo was highly expressed in the head, followed by in the ovarian tubule, and was not expressed in the testis or wings. These results suggest that BKCa plays an important physiological role in P. xylostella and provides useful information for the functional study and screening of BKCa inhibitors.


Subject(s)
Insect Proteins/genetics , Large-Conductance Calcium-Activated Potassium Channels/genetics , Moths/genetics , Transcriptome , Amino Acid Sequence , Animals , Insect Proteins/chemistry , Insect Proteins/metabolism , Large-Conductance Calcium-Activated Potassium Channels/chemistry , Large-Conductance Calcium-Activated Potassium Channels/metabolism , Larva/genetics , Larva/growth & development , Moths/growth & development , Moths/metabolism , Ovum/growth & development , Pupa/genetics , Pupa/growth & development , Sequence Alignment
4.
Asian Pac J Cancer Prev ; 16(8): 3257-65, 2015.
Article in English | MEDLINE | ID: mdl-25921129

ABSTRACT

BACKGROUND: Radiotherapy is an important treatment of choice for breast cancer patients after breast- conserving surgery, and we compare the feasibility of using dual arc volumetric modulated arc therapy (VMAT2), single arc volumetric modulated arc therapy (VMAT1) and Multi-beam Intensity Modulated Radiotherapy (M-IMRT) on patients after breast-conserving surgery. MATERIALS AND METHODS: Thirty patients with breast cancer (half right-sided and half left-sided) treated by conservative lumpectomy and requiring whole breast radiotherapy with tumor bed boost were planned with three different radiotherapy techniques: 1) VMAT1; 2) VMAT2; 3) M-IMRT. The distributions for the planning target volume (PTV) and organs at risk (OARs) were compared. Dosimetries for all the techniques were compared. RESULTS: All three techniques satisfied the dose constraint well. VMAT2 showed no obvious difference in the homogeneity index (HI) and conformity index (CI) of the PTV with respect to M-IMRT and VMAT1. VMAT2 clearly improved the treatment efficiency and can also decrease the mean dose and V5Gy of the contralateral lung. The mean dose and maximum dose of the spinal cord and contralateral breast were lower for VMAT2 than the other two techniques. The very low dose distribution (V1Gy) of the contralateral breast also showed great reduction in VMAT2 compared with the other two techniques. For the ipsilateral lung of right-sided breast cancer, the mean dose was decreased significantly in VMAT2 compared with VMAT1 and M-IMRT. The V20Gy and V30Gy of the ipsilateral lung of the left- sided breast cancer for VMAT2 showed obvious reduction compared with the other two techniques. The heart statistics of VMAT2 also decreased considerably compared to VMAT1 and M-IMRT. CONCLUSIONS: Compared to the other two techniques, the dual arc volumetric modulated arc therapy technique reduced radiation dose exposure to the organs at risk and maintained a reasonable target dose distribution.


Subject(s)
Mastectomy, Segmental , Radiotherapy, Intensity-Modulated/methods , Unilateral Breast Neoplasms/radiotherapy , Breast Neoplasms/radiotherapy , Female , Humans , Organs at Risk , Radiometry , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Adjuvant/methods , Retrospective Studies
5.
Asian Pac J Cancer Prev ; 15(16): 6649-55, 2014.
Article in English | MEDLINE | ID: mdl-25169503

ABSTRACT

Radiation therapy is an important treatment for head and neck squamous cell carcinoma (HNSCC). However, how to promote radiation sensitivity in HNSCC remains a challenge. This study aimed to investigate the radiosensitizing effects of fenofibrate on HNSCC and explore the underlying mechanisms. HNSCC cell lines CNE-2 and KB were subjected to ionizing radiation (IR), in the presence or absence of fenofibrate treatment. Cell growth and survival, apoptosis and cell cycle were evaluated. In addition, CNE-2 cells were xenografted into nude mice and subjected to IR and/ or fenofibrate treatment. The expression of cyclinB and CDK1 was detected by Western blotting. Our results showed that fenofibrate efficiently radiosensitized HNSCC cells and xenografts in mice, and induced apoptosis and G2/M arrest via reducing the activity of the CDK1/cyclinB1 kinase complex. These data suggest that fenofibrate could be a promising radiosensitizer for HNSCC radiotherapy.


Subject(s)
Apoptosis/radiation effects , Carcinoma, Squamous Cell/radiotherapy , Fenofibrate/pharmacology , Head and Neck Neoplasms/radiotherapy , M Phase Cell Cycle Checkpoints/drug effects , Radiation-Sensitizing Agents/pharmacology , Animals , Apoptosis/drug effects , CDC2 Protein Kinase , Caspase 3/biosynthesis , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Cell Survival/drug effects , Cell Survival/radiation effects , Cyclin B1/antagonists & inhibitors , Cyclin B1/metabolism , Cyclin-Dependent Kinases/antagonists & inhibitors , Cyclin-Dependent Kinases/metabolism , Humans , Male , Mice , Mice, Inbred BALB C , Radiation, Ionizing , Squamous Cell Carcinoma of Head and Neck , Xenograft Model Antitumor Assays
6.
J Pharmacol Sci ; 126(1): 56-65, 2014.
Article in English | MEDLINE | ID: mdl-25168470

ABSTRACT

IAP antagonists increased the antitumor efficacy of X-irradiation in some types of cancers, but their effects on hypoxic cancer cells remain unclarified. We aims to investigate the radiosensitizing effect of an IAP inhibitor AT-406 on cervical cancer cell lines under both normoxia and hypoxia conditions. Hela and Siha cells were treated to investigate the effects of drug administration on cell proliferation, apoptosis, and radiosensitivity. Western blot analysis was used to determine the role of AT-406 in inhibition of IAPs. The pathway of apoptosis was characterized by caspases activity assay. AT-406 potently sensitized Hela cells but not Siha cells to radiation under normoxia. Notably, the radiosensitizing effect of AT-406 on hypoxic cells was more evident than on normoxic cells in both cell lines. Further mechanism studies by western blot showed that under normoxia AT-406 decreased the level of cIAP1 in Hela cells in a dose-dependent manner; while additional downregulation of XIAP expression was induced by AT-406 treatment under hypoxia in both cell lines. Finally, AT-406 works on both extrinsic death receptor and intrinsic mitochondrial apoptosis pathways to activate apoptosis. Totally, AT-406 acts as a strong radiosensitizer in human cervical cancer cells, especially in hypoxic condition.


Subject(s)
Apoptosis/drug effects , Apoptosis/radiation effects , Azocines/pharmacology , Benzhydryl Compounds/pharmacology , Cell Proliferation/drug effects , Hypoxia/pathology , Inhibitor of Apoptosis Proteins/pharmacology , Radiation Tolerance/drug effects , Radiation-Sensitizing Agents/pharmacology , Uterine Cervical Neoplasms/pathology , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Female , HeLa Cells , Humans , Inhibitor of Apoptosis Proteins/metabolism , Mitochondria/pathology , Uterine Cervical Neoplasms/genetics , X-Linked Inhibitor of Apoptosis Protein/metabolism
7.
Tumour Biol ; 35(6): 5149-58, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24492941

ABSTRACT

To date, no scientific consensus about the associations of DR4 C626G, A683C, A1322G, and G422A polymorphisms with cancer risk has been reached. Therefore, we conducted a meta-analysis to assess the associations. This meta-analysis involved 16 studies, of which 15 (4,261 cases and 4,598 controls) described C626G genotypes, 8 (2,898 cases and 3,135 controls) described A683C genotypes, 6 (1,564 cases and 1,673 controls) described A1322G genotypes, and 5 (584 cases and 607 controls) described A683C genotypes. We associated all the four polymorphisms with cancer risk. The C626G polymorphism was associated with slightly elevated cancer risk in recession model comparison [odds ratio (OR)=1.12, 95 % confidence interval (CI)=1.00-1.26, P heterogeneity=0.425]. In the subgroup analysis by cancer type, significantly elevated cancer risks were found among groups with lung cancer for heterozygote comparison (OR=1.76, 95 % CI=1.00-3.09, P heterogeneity=0.863). The A1322G polymorphism was associated with significantly elevated cancer risk in the different models (heterozygote comparison: OR=1.21, 95 % CI=1.00-1.46, P heterogeneity=0.347; dominant model: OR=1.21, 95 % CI=1.01-1.46, P heterogeneity=0.189; allele model comparison for G allele vs. A allele: OR=1.17, 95 % CI=1.02-1.35, P heterogeneity=0.173). The A683C and G422A polymorphisms were not associated with cancer risk in all genetic models. The C626G and A1322G polymorphisms are associated with increased cancer risk, but the A683C polymorphism is rarely associated with cancer risk.


Subject(s)
Genetic Predisposition to Disease , Neoplasms/genetics , Polymorphism, Genetic , Receptors, TNF-Related Apoptosis-Inducing Ligand/genetics , Genotype , Humans , Neoplasms/etiology , Publication Bias , Risk
SELECTION OF CITATIONS
SEARCH DETAIL